HKG: 6660

Company Drug

AIM Vaccine Receives CDE Approval for Serum-Free Rabies Vaccine Trial

Fineline Cube Oct 24, 2022

China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving clinical trial approval from the...

Company Drug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

Company Drug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

Company Drug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link